150: Check On Mom with Kristina Deligiannidis, MD

In the Ladies' Room with Dr. Donnica

The HealthyWomen 2021 Survey reveals that moms still feel pressured to ‘do it all’ and continue to deprioritize their mental health and well-being. Ummmm. . .we needed a study to find that out?! In all seriousness, research shows that women are more likely to experience postpartum depression (PPD) if they receive little or no support from family, friends, or community after childbirth than women who receive appropriate support. With 1 in 8 mothers in the U.S. reporting experiencing symptoms of postpartum depression (PPD) each year, there is a need for greater fourth trimester (the 12 weeks following baby’s arrival) planning and support.

So what are we going to do about it? Check on Mom https://www.mycheckonmom.com is a program to help new and expectant moms create a maternal mental wellness plan and designate a group of trusted friends and family who are empowered to help her through the postpartum period. The site also features ongoing inspirational content and helpful information and tips. Here to discuss this with us today is Dr. Kristina Deligiannidis, Director, Women’s Behavioral Health of Northwell Health. Dr. Deligiannidis is a national leader in the field of perinatal depression and novel therapeutics research. Her research program includes a focus in psychoneuroendocrinology, particularly neurosteroids and hormones, and neuroimaging in women’s behavioral health. She has authored more than 50 peer-reviewed articles plus several textbook chapters and has given more than 170 scientific presentations.

Dr. Deligiannidis completed her undergraduate degrees in biology and psychology at the University of Massachusetts at Amherst. As a recipient of predoctoral intramural research training awards, she trained in molecular neuroendocrinology research at the National Institutes of Health (NIH) and the National Institute of Mental Health (NIMH). She received her medical degree from and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School. After residency, she completed a visiting fellowship and further training in multimodal neuroimaging at the Massachusetts General Hospital/Martinos Center for Biomedical Imaging.

Dr. Deligiannidis joined faculty at Zucker Hillside Hospital, the Feinstein Institutes for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in September 2016. She is board certified by the American Board of Psychiatry and Neurology and currently serves as the director of women’s behavioral health at Zucker Hillside Hospital. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle, pregnancy/postpartum and perimenopause.